G01N 2440/36
Addition of addition of other proteins or peptides
Official title: addition of addition of other proteins or peptides, e.g. SUMOylation, ubiquitination
G01N2440/36 (Addition of addition of other proteins or peptides) appears on 44 US grants and 90 published applications in this corpus.
Search patents in G01N- Granted patents
- 44
- Published applications
- 90
- Assignees
- 54
- Inventors
- 160
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 2 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 0 | 2 |
| 2012 | 1 | 2 |
| 2013 | 0 | 6 |
| 2014 | 1 | 7 |
| 2015 | 6 | 7 |
| 2016 | 4 | 9 |
| 2017 | 6 | 5 |
| 2018 | 4 | 6 |
| 2019 | 2 | 6 |
| 2020 | 4 | 2 |
| 2021 | 3 | 8 |
| 2022 | 2 | 8 |
| 2023 | 2 | 8 |
| 2024 | 2 | 4 |
| 2025 | 4 | 3 |
| 2026 | 3 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Diagnostic method based on large scale identification of post-translational modification of proteins18 Aug 2026US RE50,997 E1President and Fellows of Harvard College
- Markers specific for pluripotent stem cells, and methods of using the same10 Mar 2026US 12,571,042 B2FUJIFILM Corporation
- Method for identifying ubiquitin and ubiquitin-like enzyme activities10 Feb 2026US 12,546,780 B2Centre National De La Recherche Scientifique
- Methods of detecting UBE3A protein11 Nov 2025US 12,467,929 B2Biogen MA Inc.
- Sumo inhibitor compounds and uses thereof26 Aug 2025US 12,398,151 B2Suvalent Therapeutics, Inc.
- Markers specific for pluripotent stem cells, and methods of using the same13 Aug 2026US 2026/0234723 A1FUJIFILM Corporation
- Fluorescence-based assay for identification of protac ligands for hect-type e3 ligases23 Jul 2026US 2026/0210948 A1Purdue Research Foundation
- FRET Active E2-UBL Conjugates and Uses Thereof2 Jul 2026US 2026/0185137 A1Board of Regents, The University of Texas System
- Methods and compositions for tauopathy diagnosis and treatment25 Sep 2025US 2025/0298039 A1Children's Medical Center Corporation
- Anti-Polyubiquitin Multispecific Antibodies17 Apr 2025US 2025/0122272 A1Genentech, Inc.
Most cited
By later US patents
- Methods and compositions for targeting polyubiquitin17US 8,133,488 B2Genentech, Inc. · 2012
- Anti-polyubiquitin antibodies and methods of use10US 8,992,919 B2Genentech, Inc. · 2015
- Methods and compositions for targeting polyubiquitin5US 9,081,015 B2Genentech, Inc. · 2015
- Methods and compositions for targeting polyubiquitin5US 9,365,642 B2Genentech, Inc. · 2016
- Methods and compositions for targeting polyubiquitin4US 10,035,849 B2Genentech, Inc. · 2018